Severe hydroxychloroquine non-adherence linked to worse SLE outcomes
From Rheumatology News, 25 May 2023: Regular testing of hydroxychloroquine levels in patients with systemic lupus erythematosus – especially those who are experiencing a disease flare – could help to identify patients who are not taking their treatment and are at risk of worse outcomes. Data presented at an international congress on systemic lupus erythematosus … Continue reading Severe hydroxychloroquine non-adherence linked to worse SLE outcomes